INVESTORS & MEDIA
Corporate Governance
| Date | Name | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| Aug 21, 2023 |
EVP Research and Development
|
EVP Research and Development | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 38,335 | $833.39 | 64,765 |
| Feb 12, 2014 |
SVP Research and Development S
|
SVP Research and Development S | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 40,000 | $21.25 | 64,391 |
| May 14, 2021 |
EVP Research and Development
|
EVP Research and Development | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 40,000 | $179.13 | 64,280 |
| Nov 05, 2015 |
EVP Research and Development
|
EVP Research and Development | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 13,312 | $567.63 | 64,130 |
| Jun 19, 2012 |
SVP Res & Dev Sciences
|
SVP Res & Dev Sciences | Form 4 | Open market or private sale of non-derivative or derivative security | 9,080 | $116.41 | 64,104 |
| Aug 05, 2022 |
EVP Research and Development
|
EVP Research and Development | Form 4 | Open market or private sale of non-derivative or derivative security | 2,076 | $612.43 | 63,994 |
| Feb 12, 2020 |
EVP Research and Development
|
EVP Research and Development | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 25,000 | -- | 63,079 |
| Feb 12, 2014 |
SVP Research and Development S
|
SVP Research and Development S | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 2,619 | $324.44 | 61,772 |
| Feb 15, 2012 |
SVP Research and Development S
|
SVP Research and Development S | Form 4 | Open market or private sale of non-derivative or derivative security | 19,057 | $107.79 | 61,146 |
| Nov 21, 2012 |
SVP Res and Devel Sciences
|
SVP Res and Devel Sciences | Form 4 | Open market or private sale of non-derivative or derivative security | 13,157 | $174.47 | 61,121 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.